Erythromycin NDC 68071-3992

NDC codes

FDA NDC Directory

Product NDC (as listed)68071-3992Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68071-3992Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68071-3992-2	68071399202	1 TUBE in 1 CARTON (68071-3992-2) / 3.5 g in 1 TUBEMarketed from May 1, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Erythromycin
Generic name (nonproprietary): erythromycin
Active ingredients: Erythromycin — 5 mg/g
Dosage form: Ointment
Route: Ophthalmic
Labeler: NuCare Pharmaceuticals,Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 064030
Marketing start: Oct 18, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Macrolides (Chemical structure)
Identifiers: Product ID 68071-3992_50c8d6b3-4661-e829-e063-6294a90a919bSPL ID 50c8d6b3-4661-e829-e063-6294a90a919bSPL set ID 50c8d6b3-4660-e829-e063-6294a90a919bRxCUI 310149UNII 63937KV33DUPC 0368071399233
Pharmacologic class: Macrolide Antimicrobial; Macrolide

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468071399202 followed by a unit qualifier and the quantity

Package 68071-3992-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 1, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE: For the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to erythromycin. For prophylaxis of ophthalmia neonatorum due to N. gonorrhoeae or C. trachomatis . The effectiveness of erythromycin in the prevention of ophthalmia caused by penicillinase-producing N.gonorrhoeae is not established. For infants born to mothers with clinically apparent gonorrhea, intravenous or intramuscular injections of aqueous crystalline penicillin G should be given; a single dose of 50,000 units for term infants or 20,000 units for infants of low birth weight. Topical prophylaxis alone is inadequate for these infants.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 064030

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 064030
Product	Strength	Form · route	Labeler	Product NDC
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	ST. MARY'S MEDICAL PARK PHARMACY	60760-670
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	Redpharm Drug	67296-2128
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	Proficient Rx LP	63187-267
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	Sentiss Pharmaceuticals LLC	70244-031
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	ARMAS PHARMACEUTICALS INC.	72485-670
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	Asclemed USA, Inc.	76420-212